Senior living celebrates ‘big wins’ in proposed $1.7 trillion omnibus package
By
Kimberly Bonvissuto
Dec 21, 2022
Senior living advocates are claiming “major victories” for the industry following the release of the proposed $1.7 trillion congressional year-end spending bill on Monday.
FDA: No useful monoclonal antibody treatments left against new COVID-19 variants
Dec 05, 2022
Immunocompromised patients still can receive convalescent plasma.
Legalization of medical marijuana beneficial for cancer patients
Dec 05, 2022
A reduction was seen in the rate of one or more opioid days and in the rate of one or more pain-related hospital events.
Frailty-related fracture risk higher for seniors with cancer history
Nov 03, 2022
Cancer survivors who received chemotherapy are more likely to have fracture; the link were stronger within five years of diagnosis.
Older adults with poor-prognosis cancers commonly have preexisting conditions
Nov 02, 2022
These preexisting conditions affect functional impairment, mobility and falls.
Model estimates mortality risk in adults with dementia
Oct 14, 2022
A mortality prediction may help guide treatment and advance care planning for community-dwelling older adults with dementia.
Sigmoidoscopy has sustained effect on CRC incidence, mortality
Oct 12, 2022
A pooled analysis of four large-scale trials demonstrated the sustained effect on colorectal cancer incidence and mortality for 15 years.
More physical activity, less sitting may cut breast cancer risk
Sep 07, 2022
Lifelong physical activity or sedentary time, assessed by genotype, may be associated with risk for breast cancer.
New cancer drugs approved faster in U.S. than Europe
Jun 14, 2022
The FDA received licensing applications sooner and had shorter review times compared with the European Medicines Agency.
U.S. spends more on cancer than other countries, but without mortality benefit
Jun 01, 2022
The United States had the highest per capita spending on cancer care in 2020 but a median cancer mortality rate.
